Article
Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - A Prospective, Randomized, Double-masked, Crossover Trial
2022-12-01
Abstract excerpt
To evaluate the efficacy of 0.01% atropine eye drops in preventing myopia shift and myopia onset in premyopic children. A prospective, randomized, double-masked, placebo-controlled, crossover trial was conducted over 13 months. Sixty premyopic children aged 6–12 years with cycloplegic spherical equivalent refraction (SER) > -0.75 D and ≤ + 0.50 D in both eyes were assigned in a 1:1 ratio to receive one drop of 0.0...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c740c468-8e3d-5b03-bc88-1289fc5dbac1
- DOI
- 10.21203/rs.3.rs-2314578/v1
